<DOC>
	<DOCNO>NCT02851550</DOCNO>
	<brief_summary>Lysosomal Acid Lipase ( LAL ) deficiency rare , autosomal recessive storage disease link decrease enzymatic activity LAL , responsible intracellular accumulation cholesterol ester triglyceride . The accumulation lipid hepatocytes , Kupffer cell macrophages lead fatty liver , hepatic fibrosis evolve cirrhosis . LAL deficiency responsible significant morbidity early mortality child , adolescent adult connection multi visceral disease reach liver , gastrointestinal tract vascular endothelium . The disease cause homozygous heterozygous mutation gene ( LIPA chromosome 10q23.2-23.3 ) responsible synthesis LAL . The disease diagnose enzymatic analysis use drop blood absorb onto blot paper . Patients deficiency LAL , reduce activity enzyme . Because rarity , deficit LAL diagnose diagnosed patient liver biological disturbance / lipid profile disturbance , steatohepatitis-hepatitis ( NASH ) , steatosis ( NAFLD ) , cryptogenic cirrhosis Wilson disease . Inclusion period 12 18 month ( 100 patient ) .</brief_summary>
	<brief_title>Assessement Prevalence Lysosomal Acid Lipase Deficiency Liver Post-transplant Patients</brief_title>
	<detailed_description />
	<mesh_term>Wolman Disease</mesh_term>
	<criteria>liver posttransplant patient patient cryptogenic cirrhosis , NASH Patients without metabolic syndrome clinical , biological radiological .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>liver</keyword>
	<keyword>transplant</keyword>
	<keyword>Lysosomal Acid Lipase</keyword>
</DOC>